CompletedNCT04623138

A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Evidation Health
Principal Investigator
Ernesto Ramirez, PhD
Evidation Health
Enrollment
847 target
Eligibility
18 years · All sexes
Timeline
20202021

Study locations (1)

Collaborators

Biomedical Advanced Research and Development Authority · Eli Lilly and Company · Bill and Melinda Gates Foundation · Vir Biotechnology, Inc. · United States Department of Defense

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04623138 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials